Dr Dana Goldman Says Drug Pricing Is Being Viewed the Wrong Way

The way drugs are priced should have less in common with healthcare services and more in common with a consumer product like a computer operating system, Dana Goldman, PhD, the Leonard D. Schaeffer Chair and Director of the Schaeffer Center for Health Policy and Economics at the University of Southern California, said at AMCP's 27th Annual Meeting & Expo in San Diego on April 7-10.

The way drugs are priced should have less in common with healthcare services and more in common with a consumer product like a computer operating system, Dana Goldman, PhD, the Leonard D. Schaeffer Chair and Director of the Schaeffer Center for Health Policy and Economics at the University of Southern California, said at AMCP’s 27th Annual Meeting & Expo in San Diego on April 7-10.

“For drugs that are highly effective, we want to reward the innovators but then we want to price [the drugs] low so that everyone has access,” he explained. “And that’s going to require very different models and perhaps ones that we can take from other areas of intellectual property.”